§ 13F · FUND PROFILE
BAKER BROS. ADVISORS LP.
AUM · $20.0B (13F)Positions · 84Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$113M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | INCY | Incyte Corporation | 30.76M | $3.5B | 17.5% | ±0% |
| 2 | ONC | BeOne Medicines Ltd. | 8.80M | $2.5B | 12.6% | ±0% |
| 3 | RVMD | Revolution Medicines, Inc. | 11.44M | $2.1B | 10.7% | +20% |
| 4 | MDGL | Madrigal Pharmaceuticals, Inc. | 2.14M | $1.2B | 5.8% | ±0% |
| 5 | ACAD | ACADIA Pharmaceuticals Inc. | 42.91M | $1.1B | 5.4% | ±0% |
| 6 | KYMR | Kymera Therapeutics, Inc. | 8.66M | $993M | 5.0% | ±0% |
| 7 | INSM | Insmed Incorporated | 8.80M | $938M | 4.7% | +19% |
| 8 | CELC | Celcuity Inc. | 7.92M | $828M | 4.2% | ±0% |
| 9 | KOD | Kodiak Sciences Inc. | 19.92M | $776M | 3.9% | ±0% |
| 10 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.60M | $622M | 3.1% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE BAKER SIGNAL
AC read
BAKER BROS. ADVISORS LP is a Other fund managing $20.0 billion in assets. The fund runs a portfolio of 84 positions.
Read the full dossier →